10 Einträge gefunden

1. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

   1. Burdelski, Christoph
   2. Barreau, Ysé
   3. Simon, Ronald
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
2. PSMA expression is highly homogenous in primary prostate cancer

   1. Tsourlakis, Maria C
   2. Klein, Franka
   3. Kluth, Martina
   4. Quaas, Alexander
   5. Graefen, Markus
   6. Haese, Alexander
   7. Simon, Ronald

   2015 - Forschungsinformationssystem des UKE
3. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

   1. Grupp, Katharina
   2. Boumesli, Rebecca
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
4. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

   1. Grupp, Katharina
   2. Ospina-Klinck, Daniel
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Simon, Ronald

   2014 - Forschungsinformationssystem des UKE
5. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
6. Marked heterogeneity of ERG expression in large primary prostate cancers.

   1. Minner, Sarah
   2. Gärtner, Michael
   3. Freudenthaler, Fabian
   4. Bauer, Melanie
   5. Kluth, Martina
   6. Salomon, Georg
   7. Heinzer, Hans

   2013 - Forschungsinformationssystem des UKE
7. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
8. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
9. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

   1. Stahl, Phillip
   2. Kilgué, Adisa
   3. Tennstedt, Pierre
   4. Minner, Sarah Jane Pauline
   5. Krohn, Antje
   6. Simon, Ronald
   7. Krause, Geske

   2012 - Forschungsinformationssystem des UKE
10. Marked gene transcript level alterations occur early during radical prostatectomy.

    1. Schlomm, Thorsten
    2. Näkel, Esther
    3. Lübke, Andreas
    4. Buness, Andreas
    5. Chun, Felix
    6. Steuber, Thomas
    7. Graefen, Markus

    2008 - Forschungsinformationssystem des UKE